Ph.D. WEI-WU HE - 18 Dec 2025 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Ph.D. WEI-WU HE
Reporting Manager
WEI-WU HE, Ph.D.
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
20,761,963 shares
Disclosed Ownership
3,965,535 shares
Ownership
19%
Form type
SCHEDULE 13D/A
Filing time
18 Dec 2025, 06:01:06 UTC
Date of event
18 Dec 2025
Previous filing
20 Jun 2025
Next filing
09 Jan 2026
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WEI-WU HE, Ph.D. 19% 3,965,535 2,130,550 1,834,985 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D. 0001542073
HUIYING MEMORIAL FOUNDATION 3.1% 637,644 0 637,644 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC 5.3% 1,097,341 0 1,097,341 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P. 3.7% 753,234 0 753,234 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
ETP BIOHEALTH III FUND, L.P. 1.5% 300,000 0 300,000 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
HE Family GRAT 0.5% 100,000 0 100,000 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./Trustee